NMPA Approval

Doxazosin Mesylate Extended Release Tablets

Approval Number

国药准字H20243226

Company华润双鹤利民药业（济南）有限公司

Registration Date

February 23, 2024

Drug Information

Generic Name

甲磺酸多沙唑嗪缓释片

Dosage Form

片剂

Strength

4mg（以C₂₃H₂₅N₅O₅计）

Drug Type

化学药品

Registration Date

February 23, 2024

Company Information

Applicant Company

Company Name华润双鹤利民药业（济南）有限公司

Company Address

山东省济南市章丘区明水街道利民路1号

Manufacturing Company

Company Name华润双鹤利民药业（济南）有限公司

Company Address

山东省济南市章丘区明水街道利民路1号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

甲磺酸多沙唑嗪缓释片 - NMPA 批准文号 | MedPath